Anne Huml is a Nephrology physician affiliated with Cleveland Clinic. OpenAlex indexes 94 publications with 1,406 citations (h-index 19).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
11100 Euclid Ave
Cleveland, OH 441061716
Telephone
216-844-1000Registry record last updated 12 Sept 2013.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Veloxis Pharmaceuticals, Inc.Program year20252 payments
- AstraZeneca Pharmaceuticals LPProgram year20231 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
41.4%Calcium channel blocker15.6%Nifedipine Er52%Amlodipine Besylate49%Part D≥15 patientsBeta blocker14.3%Carvedilol66%Metoprolol Tartrate22%Metoprolol Succinate12%Part D<11 patients+ 2 more classes in this area
Metabolism & gastrointestinal
25.5%Corticosteroid21.2%Prednisone100%Part D≥37 patientsProton pump inhibitor2.2%Omeprazole100%Part D<11 patients+ 1 more class in this area
Anti-infectives
23.1%Short-acting sulfonamides20.1%Sulfamethoxazole-Trimethoprim100%Part D≥29 patientsCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor3%Valganciclovir Hcl100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
2 NIH research awards on record, funded 2016–2026 per NIH RePORTER. The latest:
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Outcomes for Patients With a Deceased Donor Kidney Offer in the New Allocation System
Kidney International Reports
2025 - Patient and Provider Attitudes Toward Patient-Facing Kidney Organ Offer Reporting
Kidney International Reports
2025 - Does the Transplant System Fail Patients Following Kidney Allograft Loss?
American Journal of Kidney Diseases
2025 - Hemodynamic Determinants of Cardiac Surgery-Associated Acute Kidney Injury
Critical Care Explorations
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Samir Kapadia, MD
Cleveland Clinic
Lars Svensson, MD
Cleveland Clinic
Mina Chung, MD
Cleveland Clinic
Gene Barnett, MD
Cleveland Clinic
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”